Literature DB >> 22042273

Asparaginases: a successful class of drugs against leukemias and lymphomas.

Vassilios I Avramis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042273     DOI: 10.1097/MPH.0b013e31823313be

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  7 in total

Review 1.  Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Authors:  Leila Amini; Sara K Silbert; Nirali N Shah; Mohamed Abou-El-Enein; Shannon L Maude; Loretta J Nastoupil; Carlos A Ramos; Renier J Brentjens; Craig S Sauter
Journal:  Nat Rev Clin Oncol       Date:  2022-03-22       Impact factor: 66.675

2.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

Review 3.  X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes.

Authors:  Anastassios C Papageorgiou
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.

Authors:  Wei-Wen Chien; Céline Le Beux; Nicolas Rachinel; Michel Julien; Claire-Emmanuelle Lacroix; Soraya Allas; Pierre Sahakian; Aurélie Cornut-Thibaut; Loïc Lionnard; Jérôme Kucharczak; Abdel Aouacheria; Thierry Abribat; Gilles Salles
Journal:  Sci Rep       Date:  2015-01-28       Impact factor: 4.379

5.  De novo transcriptome of the cosmopolitan dinoflagellate Amphidinium carterae to identify enzymes with biotechnological potential.

Authors:  Chiara Lauritano; Daniele De Luca; Alberto Ferrarini; Carla Avanzato; Andrea Minio; Francesco Esposito; Adrianna Ianora
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

6.  Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia.

Authors:  Ashkan Emadi; Najeebah A Bade; Brandi Stevenson; Zeba Singh
Journal:  Pharmaceuticals (Basel)       Date:  2016-03-10

7.  Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro.

Authors:  Wen-Jian Liu; Hua Wang; Xiong-Wen Peng; Wei-da Wang; Na-Wei Liu; Yang Wang; Yue Lu
Journal:  Onco Targets Ther       Date:  2018-10-08       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.